To make the central nervous system accessible to the full potential of protein-based therapies.
OUR VISION
To advance encapsulated cell technology as a new modality for sustained therapeutic protein delivery to the CNS.
OUR MISSION
With roots in Swiss academia, our team combines scientists who have advanced allogeneic encapsulated cell technology from preclinical research into the clinic with experienced biotech operators focused on translating the platform into CNS therapies.
OUR TEAM
A specialist network spanning world-leading neuroscience research centres, cell manufacturing and device engineering, supported by advisors in CNS medicine and advanced therapies, to advance the platform towards the clinic.
A NETWORK BUILT FOR TRANSLATION
HOW IT WORKS
Living Implants for Sustained Delivery of Therapeutic Proteins
Engineered human myoblasts continuously produce therapeutic proteins within the ultra-compact, biocompatible Myo-Pod® implant. Its semi-permeable membrane allows proteins to reach the CNS and nutrients to enter, while keeping the cells contained and protected from immune rejection.
OUR PARTNERS
Innovative Partnerships Advancing Therapeutic Solutions
